REFERENCES

1. Brunekreef B. and Holgate S.T., 2002, ‘Air Pollution and Health’, The Lancet, vol 360, issue 9341, pp 1233–1242.

2. Kampa M. and Castanas E., 2008, ‘Human Health Effects of Air Pollution’, Environmental Pollution, vol 151, issue 2, pp 362–7.

3. Senesil G.S. et al, 1999, ‘Trace element inputs into soils by anthropogenic activities and implications for human health’, Chemosphere, vol 39, issue 2, pp 343–377.

4. Patel D. and Minajagi M., 2018, ‘Prevalence of vitamin D deficiency in adult patients admitted to a psychiatric hospital’, BJPsych Bulletin, vol 42, issue 3, pp 123–126.

5. Eaton S.B. and Konnor M., 1985, ‘Paleolithic Nutrition’, New England Journal of Medicine, vol 312, no 5, pp 283–289

6. Clemente J.C., Pehrsson E.C., Blaser M.J. et al, 2015, ‘The Microbiome of uncontacted Amerindians’, Science Advances, vol 1, no 3.

7. Kaplan H., Thompson R.C., Trumble B.C. et al, 2017, ‘Coronary atherosclerosis in indigenous South American 267CCC_tx.indd 339 15/01/2021 10:04, Tsimane: a cross-sectional cohort study’, The Lancet, vol 389, issue 10080, pp 1676–1678.

8. Harari Y.N., 2011, Sapiens - A Brief History of Humankind, Vintage, London.

9. Chao A. et al, 2005, ‘Meat consumption and risk of colorectal cancer’, JAMA, vol 293, issue 2, pp 172–182.

10. Larsson S.C. and Wolk A., 2012, ‘Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies’, Br Jnl Cancer, vol 106, issue 3, p 603.

11. Krajcovicova-Kudlackova M. et al, 2000, ‘Correlation of Carnitine levels to Methionine and Lysine intake’, Physiol Res, vol 49, pp 399–402.

12. Laidlaw S.A. et al, 1988, ‘Plasma and urine taurine levels in vegans’, Am J Clin Nutr, vol 47, pp 660–663.

13. Schmidt J.A., 2016, ‘Plasma concentrations and intakes of amino acids in male meat-eaters, fish-eaters, vegetarians and vegans: a cross-sectional analysis in the EPIC-Oxford cohort’, European Journal of Clinical Nutrition, vol 70, pp 306–312.

14. Tang G., Qin J., Dolnikowski G. et al, 2003, ‘Short-term (intestinal) and long-term (postintestinal) conversion of beta-carotene to retinol in adults as assessed by a stable-isotope reference method’, Am J Clin Nutr, vol 78, issue 2, pp 259–266.

15. 15 Afshin, A., 2019, ‘Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017’, The Lancet, vol 393, issue 10184, pp 1958–1972.

16. 16 Verhoeven D.T. et al, 1996, ‘Epidemiological studies on 267CCC_tx.indd 340 15/01/2021 10:04 brassica vegetables and cancer risk’, Cancer Epidemiol, Biomarkers Prev, vol 5, issue 9, pp 733–748.

17. Yu M.C., et al, 2002, ‘Arylamine exposures and bladder cancer risk’, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vols 506–507, pp 21–28.

18. Kobylewski S. and Jacobson M.F., 2012, ‘Toxicology of Food Dyes’, International Journal of Occupational and Environmental Health, vol 18, issue 3, pp 220–246.

19. Oplatowska-Stachowiak M. and Elliott C.T., 2017, ‘Food Colors: Existing and emerging food safety concerns’, Critical Reviews in Food Science and Nutrition, vol 57, issue 3, pp 524–528.

20. Iyyaswamy, A. and Rathinasamy, S. (2012), ‘Effect of chronic exposure to aspartame on oxidative stress in discrete brain regions of albino rats’, Journal of Biosciences, vol. 37, issue 4, pp. 679–688.

21. Stegink, L.D., Brummel, M.C., Filer, L.J. and Baker, G.L. (1983), ‘Blood methanol concentrations in one-year-old infants administered graded doses of aspartame’, The Journal of Nutrition, vol. 113, issue 8, pp. 1600–1606.

22. Trocho, C., Pardo, R., Rafecas, I. et al. (1998), ‘Formaldehyde derived from dietary aspartame binds to tissue components in vivo’, Life Sciences, vol. 63, issue 5, pp. 337–349.

23. Abhilash, M., Sauganth Paul, M.V., Matthews, V. et al. (2011), ‘Effect of long-term intake of aspartame on antioxidant defence status in liver’, Food and Chemical Toxicology, vol. 49, issue 6, pp. 1203–1207.

24. Pisarik, P. and Kai, D. (2009), ‘Vestibulocochlear toxicity in a pair of siblings 15 years apart secondary to aspartame: two case reports’, Cases Journal, vol. 2, p. 9237.

25. Briffa, J. (2005), ‘Aspartame and its effects on health’, British Medical Journal, vol. 330, issue 7486, pp. 309–310.

26. Nagagawa, Y., Nagasawa, M., Yamada, S. et al. (2009), ‘Sweet taste receptor expressed in pancreatic beta-cells activates the calcium and cyclic AMP signalling systems and stimulates insulin secretion’, PLoS One, vol. 4, issue 4, e5106.

27. Pepino, M.Y. et al. (2013), ‘Sucralose affects glycemic and hormonal response to an oral glucose load’, Diabetes Care, DC 122221.

28. Mackenzie-Ross, S.J. et al. (2010), ‘Neuropsychological and psychiatric functioning in sheep farmers exposed to low levels of organophosphate pesticides’, Neurotoxicology and Teratology, vol. 32, issue 4, pp. 452–459.

29. Kamel, F. and Hoppin, J.A. (2004), ‘Association of pesticide exposure with neurologic dysfunction and disease’, Environmental Health Perspectives, vol. 112, issue 9, pp. 950–958.

30. Spiewak, R. (2001), ‘Pesticides as a cause of occupational skin diseases in farmers’, Annals of Agricultural and Environmental Medicine, vol. 8, pp. 1–5.

31. The BSE Inquiry Report (1999), UK Government, vol. 12, section 10, statement 523, issued 23.09.1999. Patrick Holden, Director, Soil Association. Archived 25.05.2006.

32. Thomas, D. (2003), ‘A study on the mineral depletion of the foods available to us as a nation over the period 1940 to 1991’, Nutrition and Health, 1 April 2003.

33. Davis, D.R. (2009), ‘Declining fruit and vegetable nutrient composition: what is the evidence?’, HortScience, vol. 44, no. 1, pp. 15–19.

34. White, P.J. and Broadley, M.R. (2005), ‘Historical variation in the mineral composition of edible horticultural products’, The Journal of Horticultural Science and Biotechnology, vol. 80, issue 6, pp. 660–667.

35. Lawrence, F. (2013), Not on the Label, Penguin Books, London.

36. Cameron, E. and Pauling, L. (1976), ‘Supplemental ascorbate in the supportive treatment of cancer: prolongation of survival times in terminal human cancer’, Proceedings of the National Academy of Sciences of the United States of America (PNAS), vol. 73, issue 10, pp. 3685–3689.

37. Yun, J. et al. (2015), ‘Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH’, Science, vol. 350, issue 6266, pp. 1391–1396.

38. Ohno, S. et al. (2009), ‘High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer’, Anticancer Research, vol. 29, no. 3, pp. 809–815.

39. Block, G. (1991), ‘Vitamin C and cancer prevention: the epidemiologic evidence’, The American Journal of Clinical Nutrition, vol. 53, issue 1, pp. 270S–282S.

40. Clement, I. (1998), ‘Lessons from basic research in selenium and cancer prevention’, The Journal of Nutrition, vol. 128, issue 11, pp. 1845–1854.

41. Clark, L.C., Combs, G.F., Turnbull, B.W. et al. (1996), ‘Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin: a randomized controlled trial’, JAMA, vol. 276, issue 24, pp. 1957–1963.

42. Eskin, B.A. et al. (1967), ‘Mammary gland dysplasia in iodine deficiency: studies in rats’, JAMA, vol. 200, issue 8, pp. 691–695.

43. Stadel, B.V. (1976), ‘Dietary iodine and risk of breast, endometrial and ovarian cancer’, The Lancet, vol. 307, issue 7965, pp. 890–891.

44. Booth, R. (2019), ‘UK councils rethink use of weedkillers after US cases’, The Guardian, 6 April 2019.

45. Kishi, M. (2002), ‘Initial summary of the main factors contributing to incidents of acute pesticide poisoning’, World Health Organisation, 6 June 2002.

46. Hurst, A.F. and Knott, F.A. (1931), ‘Intestinal carbohydrate dyspepsia’, QJM: An International Journal of Medicine, vol. os-24, issue 94, pp. 171–179.

47. Winner, H.I. and Hurley, R. (1964), Candida Albicans, Churchill, London.

48. Truss, O. (1978), ‘Tissue injury induced by Candida albicans – mental and neurologic manifestations’, Journal of Orthomolecular Psychiatry, vol. 7, pp. 17–37.

49. Truss, O. (1984), ‘Metabolic abnormalities in patients with chronic candidiasis – the acetaldehyde hypothesis’, Journal of Orthomolecular Psychiatry, vol. 13, issue 2, pp. 66–93.

50. Crook, W.G. (1986), The Yeast Connection, Professional Books, Tennessee.

51. Hunnisett A., Howard J., Davies S. (1990). Gut Fermentation (“Auto-brewery”) Syndrome: A New Clinical Test and Discussion. J Nutr Med, 1(1), 33–38.

52. Galland L., Barrie S. (1993). Intestinal Dysbiosis and Disease Causes. J Adv Med, 6, 67–82.

53. Eaton K.K. et al. (2001). Lactulose Breath Hydrogen vs Gut Fermentation Profiles in Fungal Dysbiosis. J Nutr Environ Med, 11(1), 33–42.

54. Eaton K.K. et al. (2002). Gastric Acid, Pancreatic Secretions and Higher Alcohols in Fungal Dysbiosis. J Nutr Environ Med, 12(2), 107–112.

55. Eaton K.K. et al. (2004). Gut Fermentation: Reappraisal, Diagnostics and Management. J Nutr Environ Med, 14(2), 89–94.

56. Mosley M. (2017). The Clever Guts Diet, p. 60. Short Books, London.

57. Fasano A. (2012). Leaky Gut and Autoimmune Disease. Clin Rev Allergy Immunol, 42(1), 71–78.

58. Hollander D. (1999). Intestinal Permeability and Disorders. Curr Gastroenterol Rep, 1(5), 410–416.

59. Burkitt D.P. et al. (1974). Dietary Fiber and Disease. JAMA, 229, 1068–73.

60. Ramachandran M., Aronson J.K. (2011). John Bostock’s Hayfever Description. J R Soc Med, 104(6), 237–240.

61. Behrendt H. et al. (2014). Environmental Pollution and Allergy – History. Chem Immunol Allergy, 100, 268–277.

62. Miller C.S. (2001). Toxicant-induced Loss of Tolerance. J Nutr Environ Med, 11(3), 181–204.

63. Okuyama Y. et al. (2007). Air Pollutant Adsorption on Japanese Cedar Pollen. Atmos Environ, 41(2), 253–260.

64. Gray S.L. et al. (2015). Anticholinergics and Dementia Risk. JAMA Intern Med, 175(3), 401–407.

65. Matta M.K. et al. (2019). Sunscreen Use and Plasma Levels of Active Ingredients. JAMA, 321(21), 2082–2091.

66. Calafat A.M. et al. (2008). Benzophenone-3 Levels in US Residents. Environ Health Perspect, 116(7), 893–897.

67. Draelos Z.D. (2010). Are Sunscreens Safe? (Editorial). J Cosmet Dermatol, 9(1).

68. Graham-Brown R., Burns T. (2002). Lecture Notes on Dermatology. Blackwell, Oxford.

69. Shuster S. (2010, July 21). Don’t Let Melanoma Scare Keep You Out of the Sun. The Guardian.

70. Berwick M. et al. (2005). Sun Exposure and Melanoma Mortality. J Natl Cancer Inst, 97(3), 195–200.

71. Hill N. et al. (2005). Bug Buster Kit vs OTC Lice Treatments (UK). BMJ, 331, 384–387.

72. Jägerstad M., Skog K. (2005). Genotoxicity of Heat-Processed Foods. Mutat Res, 574(1–2), 156–172.

73. Trafialek J., Kolanowski W. (2013). Estimating Carcinogen Risk from Meat Consumption. Int J Food Sci Nutr, 65(6), 774–780.

74. Mueller M.S. et al. (2004). RCT of Artemisia annua for Malaria. Trans R Soc Trop Med Hyg, 98(5), 318–321.

75. Bendich A., Langseth L. (1995). Vitamin C Supplementation: Health Effects Review. J Am Coll Nutr, 14(2), 124–136.

76. Block G. (1991). Vitamin C and Cancer: Epidemiologic Evidence. Am J Clin Nutr, 54(6), 1310S–1314S.

77. Singer S.R., Grismaijer S. (1995). Dressed to Kill: Bras and Breast Cancer. Avery, New York.

78. Herr I., Büschler M.W. (2010). Cruciferous Vegetables and Cancer. Cancer Treat Rev, 36(5), 377–383).

79. Lawrence F. (2013). Not On The Label. Penguin, London.

80. Chazelas E. et al. (2019). Sugary Drink Intake and Cancer Risk. BMJ, 366, 12408.

81. Freedman B.J. (1980). Sulphur Dioxide in Food and Asthma. Br J Dis Chest, 74(2), 128–134.

82. Zaraska M. (2015). Bitter Truth. New Scientist, 227(3032), 26–29.

83. Kemp T.J. et al. (1996). Dust Mite Allergen in Pillows. BMJ, 313, 916.

84. Moss M., Freed D. (2003). Cow’s Milk and Coronary Disease. Int J Cardiol, 87(2–3), 203–216.

85. Bellingham M., Sharpe R.M. (2013). Chemical Exposure in Pregnancy. RCOG Sci Impact Paper 37, May.

86. Sarangi S. et al. (2010). Bhopal Disaster: Parental Exposure and Offspring. Am J Ind Med, 3(8), 836–841.

87. Debes F. et al. (2006). Prenatal Methylmercury Exposure and Neurofunction at 14. Neurotoxicol Teratol, 28(5), 536–547.

88. Palmer R.F., Blanchard S., Wood R. (2009). Proximity to Mercury Sources and Autism Prevalence. Health Place, 15(1), 18–24.

89. Bernard S. et al. (2001). Autism: Novel Mercury Poisoning Hypothesis. Med Hypotheses, 56(4), 462–471.

90. Kalter H., Warkany J. (1957). Riboflavin Deficiency and Malformations in Mice. J Exp Zool, 136(3).

91. Wehby G., Murray J.C. (2010). Folic Acid and Orofacial Clefts: Review. Oral Dis, 16(1), 11–19.

92. Smithells, R.W., Sheppard, S., Schorah, C.J., et al. (1980). Possible prevention of neural-tube defects by periconceptional vitamin supplementation. The Lancet, 315(8164), 339–340.

93. Smithells, R.W., Nevin, N.C., Seller, M.J., et al. (1983). Further experience of vitamin supplementation for prevention of neural tube defect recurrences. The Lancet, 321(8332), 1027–1031.

94. Laurence, K.M. (1966). The survival of untreated spina bifida cystica. Developmental Medicine & Child Neurology, 8(s11), 10–19.

95. Mweshi, M.M., Mwendaweli, E., Siziya, S., et al. (2015). Ethnic pattern of origin of children with spina bifida managed at the University Teaching Hospital and Beit Cure Hospital, Lusaka, Zambia 2001–2010. Science Journal of Public Health, 3(6), 857–861.

96. Li, Z., Ren, A., Zhang, L., et al. (2006). A population-based case-control study of risk factors for neural tube defects in four high-prevalence areas of Shanxi province, China. Paediatric and Perinatal Epidemiology, 20(1), 43–53.

97. Ahern, M.M., Hendryx, M., Conley, J., et al. (2011). The association between mountaintop mining and birth defects among live births in central Appalachia, 1996–2003. Environmental Research, 111(6), 838–846.

98. Favier, A.E. (1992). The role of zinc in reproduction. Biological Trace Element Research, 32(1–3), 363–382.

99. Keen, C.L. & Hurley, L.S. (1989). Zinc and reproduction: Effects of deficiency on foetal and postnatal development. In Mills, C.F. (Ed.), Zinc in Human Biology (pp. 183–220). Springer.

100. Pieczynska, J., & Grajeta, H. (2015). The role of selenium in human conception and pregnancy. Journal of Trace Elements in Medicine and Biology, 29, 31–38.

101. Hetzel, B.S. (1983). Iodine deficiency disorders (IDD) and their eradication. The Lancet, 322(8359), 1126–1129.

102. Spätling, L. & Spätling, G. (1988). Magnesium supplementation in pregnancy. A double-blind study. British Journal of Obstetrics and Gynaecology, 95, 120–125.

103. The Magpie Trial Collaborative Group. (2002). Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. The Lancet, 359(9321), 1877–1890.

104. Downing, D. (2002). Personal communication.

105. Leiser, C.L., Hanson, H.A., Sawyer, K., et al. (2019). Acute effects of air pollutants on spontaneous pregnancy loss: a case-crossover study. Fertility and Sterility, 111(2), 341–347

106. Lacasana, M., Esplugues, A., & Ballester, F. (2005). Exposure to ambient air pollution and prenatal and early childhood health effects. European Journal of Epidemiology, 20(2), 183–199.

107. Salama, A.K., Bakry, N.M., & Abou-Donia, M.B. (1993). A review article on placental transfer of pesticides. International Journal of Occupational Medicine & Toxicology, 2(4), 383–397.

108. Agarwal, A., Deepinder, F., Sharma, R.K., et al. (2008). Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study. Fertility and Sterility, 89(1), 124–128.

109. Levine, H., Jørgensen, N., Martino-Andrade, A., et al. (2017). Temporal trends in sperm count: a systematic review and meta-regression analysis. Human Reproduction Update, 23(6), 646–659.

110. Walker, M. (1993). A fresh look at the risks of artificial feeding. Journal of Human Lactation, 9, 97–107

111. Karjalainen, J., Martin, J.M., Knip, M., et al. (1992). A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. New England Journal of Medicine, 327, 302–307.

112. Lopez-Alarcon, M., Villalpando, S., & Fajardo, A. (1997). Breastfeeding lowers the frequency and duration of acute respiratory infection and diarrhoea in infants under 6 months of age. Journal of Nutrition, 127, 436–443.

113. Silfverdal, S.A., Ekholm, L., Bodin, L., et al. (1997). Protective effect of breastfeeding on invasive Haemophilus influenzae infection: a case-control study in Swedish pre-school children. International Journal of Epidemiology, 26, 443–450.

114. Dagan, R., & Pridan, H. (1982). Relationship of breastfeeding versus bottle feeding with emergency room visits and hospitalization for infectious diseases. European Journal of Pediatrics, 139(3), 192–194.

115. Pisacane, A., Graziano, L., Mazzarella, G., et al. (1992). Breastfeeding and urinary tract infection. Journal of Pediatrics, 120, 87–89.

116. Duffy, L.C., Faden, H., Wasielewski, R., et al. (1997). Exclusive breastfeeding protects against bacterial colonisation and daycare exposure to otitis media. Pediatrics, 100(4), E7.

117. Aniansson, G., Alm, B., Andersson, B., et al. (1994). A prospective cohort study on breastfeeding and otitis media in Swedish infants. Pediatric Infectious Disease Journal, 13, 183–188.

118. Davis, M.K., Savitz, D.A., & Graubard, B.I. (1988). Infant feeding and childhood cancer. The Lancet, 2, 365–368.

119. Mitchell, E.A., Ford, R.P., Stewart, A.W., et al. (1991). Results from the first year of the New Zealand cot death study. New Zealand Medical Journal, 104, 71–76.

120. Wright, A.L., Holberg, C.J., Taussig, L.M., et al. (1995). Relationship of infant feeding to recurrent wheezing at age 6 years. Archives of Pediatrics & Adolescent Medicine, 149, 758–763.

121. Koletzko, S., Sherman, P., Corey, M., et al. (1989). Role of infant feeding practices in the development of Crohn’s disease in childhood. BMJ, 298, 1617–1618.

122. Horwood, L.J. & Fergusson, D.M. (1998). Breastfeeding and later cognitive and academic outcomes. Pediatrics, 101, e9.

123. Lucas, A., Morley, R., Cole, T.J., et al. (1992). Breast milk and subsequent intelligence quotient in children born preterm. The Lancet, 339(8788), 261–264.

124. Andraca, I., & Uauy, R. (1995). Breastfeeding for optimal mental development. In Simopoulos, A.P., Dutra de Oliveira, J.E., & Desai, I.D. (Eds.), Behavioural and Metabolic Aspects of Breastfeeding, World Review of Nutrition and Dietetics, 78, 1–27. Karger, Basel.

125. Taylor, B., & Wadsworth, J. (1984). Breastfeeding and child development at five years. Developmental Medicine & Child Neurology, 26, 73–80.

126. Newman, J. (1995). How breastfeeding protects newborns. Scientific American, 273, 76–79.

127. Newcombe, P.A., Storer, B.E., Longnecker, M.P., et al. (1994). Lactation and a reduced risk of premenopausal breast cancer. New England Journal of Medicine, 330, 81–87.

128. Romieu, I., Hernandez-Avila, M., Lazcano-Ponce, E., et al. (1996). Breast cancer and lactation history in Mexican women. American Journal of Epidemiology, 143, 543–552.

129. Enger, S.M., Ross, R.K., Paganini-Hill, A., et al. (1997). Breastfeeding history, pregnancy experience and risk of breast cancer. British Journal of Cancer, 76(1), 118–123.

130. Brun J.G. et al, 1995, ‘Breastfeeding, other reproductive factors and rheumatoid arthritis: a prospective study’, Br J Rheumatology, vol 34, pp 542–546.

131. Altemus L. et al, 1995, ‘Suppression of hypothalamic-pituitary-adrenal axis responses to stress in lactating women’, J Clin Endocrinol Metab, vol 80, pp 2954–2959.

132. Tarrant R.C. et al, 2012, ‘The positive role of breastfeeding on infant health during the first 6 weeks: findings from a prospective observational study based on maternal reports’, Ir Med J, vol 105, issue 3, pp 75–78.

133. Oddy W.H. et al, 2003, ‘Breastfeeding and respiratory morbidity in infancy: a birth cohort study’, Arch Dis Child, vol 88, issue 3, pp 224–228.

134. Flores-Pajot M.C. et al, 2016, ‘Childhood autism spectrum

     disorders and exposure to nitrogen dioxide and particulate matter air pollution: a review and meta-analysis’, Environmental Research, vol 151, pp 763–776.

135. Grandjean P. and Landrigan P.J., 2014, ‘Neurobehavioural effects of developmental toxicity’, The Lancet Neurology, vol 13, issue 3, pp 330–338.

136. Farrow C. and Haycraft E., 2019, ‘Do play with your food!’, The Psychologist, British Psychological Society, vol 32, pp 22–25.

137. Dame Sally Davies, Chief Medical Officer. “Antibiotic resistance as big a threat as climate change – chief medic.” The Guardian, 29th April 2019.

138. Walton S., Wyatt E.H., and Cunliffe W.J. (1988). “Genetic control of sebum excretion and acne – a twin study.” British Journal of Dermatology, 118(3): 393–396.

139. Blythman, J. (2015). Swallow This. Fourth Estate, London.

140. Kranjcec B., Papes D., Altarac S. (2014). “D-mannose powder for prophylaxis of recurrent urinary tract infections in women; a randomized clinical trial.” World Journal of Urology, 32(1): 79–84.

141. Liu G. et al. (2015). “Nickel exposure is associated with the prevalence of type 2 diabetes in Chinese adults.” International Journal of Epidemiology, 44(1): 240–248.

142. Horak E. et al. (1978). “Effects of nickel chloride and nickel carbonyl upon glucose metabolism in rats.” Annals of Clinical and Laboratory Science, 8(6): 476–482.

143. Golbidi S. et al. (2011). “Diabetes and alpha lipoic acid.” Frontiers in Pharmacology, 2:69.

144. Packer L., Kraemer K., Rimbach G. (2001). “Molecular aspects of lipoic acid in the prevention of diabetes complications.” Nutrition, 17(10): 888–895.

145. Porta M. (2006). “Persistent Organic Pollutants and the burden of Diabetes.” The Lancet, 368(9535): 558–559.

146. Scannapieco F.A., Bush R.B., Paju S. (2003). “Associations Between Periodontal Disease and Risk for Atherosclerosis, Cardiovascular Disease and Stroke. A Systematic Review.” Annals of Periodontology, 8(1): 38–53.

147. Downing, D. (1988). Day Light Robbery: The importance of sunlight to health. Arrow Books, London.

148. Darbre P. (2016). “Aluminium and the human breast.” Morphologie, 100(329): 65–74.

149. Gupta V.B. et al. (2005). “Aluminium in Alzheimer’s disease: are we still at a crossroad?” Cellular and Molecular Life Sciences, 62(2): 143–158.

150. Beral V. et al. (1999). “Use of HRT and the subsequent risk of cancer.” Journal of Epidemiology and Biostatistics, 4(3): 191–210.

151. Mahmud K. (2009). “Natural hormone therapy for menopause.” Gynecological Endocrinology, 26(2): 81–85.

152. Aaseth J., Boivin G., Anderson O. (2012). “Osteoporosis and trace elements – An overview.” Journal of Trace Elements in Medicine and Biology, 26(2–3): 149–152.

153. Hedlund L.R., Gallagher J.C. (1989). “Increased incidence of hip fracture in osteoporotic women treated with sodium fluoride.” Journal of Bone and Mineral Research, 4(2): 223–225.

154. Gutteridge D.H. et al. (1990). “Spontaneous hip fractures in fluoride-treated patients: Potential causative factors.” Journal of Bone and Mineral Research, 5(S1): S205–S215.

155. Sebastian A. et al. (2001). “Dietary ratio of animal to vegetable protein and rate of bone loss and risk of fracture in postmenopausal women.” American Journal of Clinical Nutrition, 74(3): 411–412.

156. Heikkinen S. et al. (2015). “Does Hair Dye Use Increase the Risk of Breast Cancer? A Population-Based Case-Control Study of Finnish Women.” PLOS ONE, 10(8): e0135190.

157. Hamdouk M.I. et al. (2008). “Paraphenylene diamine hair dye poisoning.” In Clinical Nephrotoxins, Springer, Boston, pp. 871–879.

158. Campbell A. (2002). “The potential role of aluminium in Alzheimer’s disease.” Nephrology Dialysis Transplantation, 17(Suppl 2): 17–20.

159. De la Monte S.M., Wands J.R. (2008). “Alzheimer’s Disease is Type 3 Diabetes – Evidence Reviewed.” Journal of Diabetes Science and Technology, 2(6): 1101–1113.

160. Clayton P., Rowbotham J. (2008). “An unsuitable and degraded diet? Part one: public health lessons from the mid-Victorian working class diet.” Journal of the Royal Society of Medicine, 101: 282–289.

161. Smith M., Atkin A., Cutler C. (2017). “An Age Old Problem? Estimating the Impact of Dementia on Past Human Populations.” Journal of Aging and Health, 29(1): 68–98.

162. Fox M. (2018). “Evolutionary medicine perspectives on Alzheimer’s Disease: Review and new directions.” Ageing Research Reviews, 47: 140–148.

163. Grimes D.S., Hindle E., Dyer T. (1996). “Sunlight, cholesterol and coronary heart disease.” QJM: An International Journal of Medicine, 89: 579–589.

164. Martyn C.L. et al. (1989). “Geographical relation between Alzheimer’s disease and aluminium in drinking water.” The Lancet, 333(8629): 59–62.

165. Crapper D.R., Krishnan S.S., Quittkat S. (1976). “Aluminium, neurofibrillary degeneration and Alzheimer’s disease.” Brain, 99(1): 67–80.

166. Casacuberta N. et al. (2009). “Radioactivity contents in dicalcium phosphate and the potential radiological risk to human populations.” Journal of Hazardous Materials, 170(2–3): 814–823.

167. Schiffman S.S., Rother K.I. (2013). “Sucralose, a synthetic organochlorine sweetener: overview of biological issues.” Journal of Toxicology and Environmental Health, Part B, 16(7): 399–451.

168. Abou-Donia M.B. (2008). “Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats.” Journal of Toxicology and Environmental Health, Part A, 71(21): 1415–1429.

169. Dong S. et al. (2013). “Polychlorinated dibenzo-p-dioxins and dibenzofurans formed from sucralose at high temperatures.” Scientific Reports, 3: 2946.

170. BBC Radio 4. The Food Programme, Sunday 9th June 2019.

171. Hodges R.E., Minich D.M. (2015). “Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application.” Journal of Nutrition and Metabolism.

172. Schraufnagel D.E. et al. (2019). “Air Pollution and Non-communicable Diseases.” Chest, 155(2): 409–416.

173. Landrigan P. et al. (2017). “The Lancet Commission on pollution and health.” The Lancet, 391(10119): 462–512.

174. Michaelis S. (2010). “Health and Flight Safety Implications from Exposure to Contaminated Air in Aircraft.” Doctoral dissertation, University of New South Wales. http://www.susanmichaelis.com/phd.htm

175. Mackenzie Ross S. et al. (2011). Cognitive function following reported exposure to contaminated air on commercial aircraft: methodological considerations for future researchers. Journal of Biological Physics and Chemistry, 11, 180–191.

176. Mackenzie Ross S. (2008). Cognitive function following exposure to contaminated air on commercial aircraft: A case series of 27 pilots seen for clinical purposes. Journal of Nutritional and Environmental Medicine, 17(2), 111–126.

177. Schindler B.K. et al. (2013). Occupational exposures of air crews to tricresyl phosphate isomers and organophosphate flame retardants after fume events. Archives of Toxicology, 87(4), 645–648.

178. Winder C., & Balouet J-C. (2002). The toxicity of commercial jet oils. Environmental Research, 89(2), 146–164.

179. National Toxicology Program. (1987). NTP Toxicology and Carcinogenesis Studies of 1,4–Dichlorobenzene in Rats and Mice. National Toxicology Program Technical Report Series, 319, 1–198.

180. Passon D. (2011). The international crew health survey. Journal of Biological Physics and Chemistry, 11, 201–207.

181. Salmi H.A., & Sarna S. (1982). Effect of silymarin on chemical, functional and morphological alterations of the liver. Scandinavian Journal of Gastroenterology, 17, 517–521.

182. Furlong C.E. et al. (2005). Role of paraoxonase (PON1) status in pesticide sensitivity: genetic and temporal determinants. Neurotoxicology, 26(4), 651–659.

183. Aleynik S.I. et al. (1997). Polyenylphosphatidylcholine prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis. Journal of Hepatology, 27(3), 554–561.

184. McNeely E. et al. (2018). Cancer prevalence among flight attendants compared to the general population. Environmental Health, 17(1), 49.

185. Michaelis S. (2011). Contaminated aircraft cabin air. Journal of Biological Physics and Chemistry, 11(4), 132–145.

186. Winder C., & Michaelis S. (2005). Crew effects from toxic exposures on aircraft. In: Air Quality in Airplane Cabins and Similar Enclosed Spaces. The Handbook of Environmental Chemistry, pp. 229–248.

187. Harrison V., & Mackenzie Ross S. (2016). An emerging concern: Toxic fumes in airplane cabins. Cortex, 74, 297–302.

188. Abou-Donia M.B. et al. (2013). Autoantibodies to nervous system-specific proteins are elevated in sera of flight crew members: Biomarkers for nervous system injury. Journal of Toxicology and Environmental Health, Part A, 76, 363–380.

189. Thompson C.M. et al. (1988). Regional brain trace-element studies in Alzheimer’s disease. NeuroToxicology, 9(1), 1–8.

190. Pendergrass J.C. et al. (1997). Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: Similarity to a molecular lesion in Alzheimer diseased brain. NeuroToxicology, 18(2), 315–324.

191. Needleman H.L. et al. (1996). Bone lead levels and delinquent behaviour. JAMA, 275(5), 363–369.

192. Brockel B.J., & Cory-Slechter D.A. (1998). Lead, attention and impulsive behaviour: changes in a fixed-ratio waiting-for-reward paradigm. Pharmacology Biochemistry and Behavior, 60(2), 545–552.

193. Grimsrud T.K. et al. (2003). Lung cancer incidence among Norwegian nickel-refinery workers 1953–2000. Journal of Environmental Monitoring, 5(2), 190–197.

194. Yang Y. et al. (2008). Urinary level of nickel and acute leukaemia in Chinese children. Toxicology and Industrial Health, 24(9), 603–610.

195. Mold M. et al. (2018). Aluminium in brain tissue in autism. Journal of Trace Elements in Medicine and Biology, 4, 76–82.

196. Darbre P.D., Mannello F., & Exley C. (2013). Aluminium and breast cancer: Sources of exposure, tissue measurements and mechanisms of toxicological actions on breast biology. Journal of Inorganic Biochemistry, 128, 257–261.

197. Buha A. et al. (2019). Bone mineral health is sensitively related to environmental cadmium exposure – experimental and human data. Environmental Research, 176.

198. Djordjevic V.R. et al. (2019). Environmental cadmium exposure and pancreatic cancer: Evidence from case-control, animal and in vitro studies. Environment International, 128, 353–361.

199. Störtebecker P. (1989). Mercury poisoning from dental amalgam through direct nose-brain transport. The Lancet, 1, 1207.

200. Vimy M., & Lorscheider F.L. (1985). Clinical Science: Intra-oral air mercury released from dental amalgam. Journal of Dental Research, 64(8), 1072–1075.

201. Lorscheider F.L., Vimy M.J., & Summers A.O. (1995). Mercury exposure from “silver” tooth fillings: emerging evidence questions a traditional dental paradigm. FASEB Journal, 9, 504–508.

202. Nylander M., Friberg L., & Lind B. (1987). Mercury concentrations in the human brain and kidney in relation to exposure from dental amalgam fillings. Swedish Dental Journal, 11(5), 179–187.

203. Uzzell B.P., & Oler J. (1986). Chronic low-level mercury exposure and neuropsychological functioning. Journal of Clinical and Experimental Neuropsychology, 8(5), 581–593.

204. Mutter J. et al. (2010). Does inorganic mercury play a role in Alzheimer’s disease? A systematic review and an integrated molecular mechanism. Journal of Alzheimer’s Disease, 22(2), 357–374.

205. Brownstein D. (2009). Iodine: Why You Need It, Why You Can’t Live Without It. Medical Alternatives Press, Michigan.

206. Bassin E.B. (2001). Association between fluoride in drinking water during growth and development and the incidence of osteosarcoma for children and adolescents. Doctoral thesis, Harvard School of Dental Medicine, Boston, Massachusetts.

207. Lantz O. et al. (1987). Fluoride-induced chronic renal failure. American Journal of Kidney Diseases, 10(2), 136–139.

208. National Research Council. (2006). Fluoride in Drinking Water: A Scientific Review of EPA’s Standards, Chapter 7: Neurotoxicity and Neurobehavioural Effects. National Academies Press, Washington DC.

209. Doyle T.J. et al. (1997). The association of drinking water source and chlorination by-products with cancer incidence among post-menopausal women in Iowa: a prospective cohort study. American Journal of Public Health, 87(7), 1168–1176.

210. Bernard A. et al. (2003). Lung hyperpermeability and asthma prevalence in schoolchildren: Unexpected associations with the attendance at indoor chlorinated swimming pools. Occupational and Environmental Medicine, 60(6), 385–394.

211. van Leeuwen F.X.R. et al. (1983). Toxicity of sodium bromide in rats: Effects on endocrine system and reproduction. Food and Chemical Toxicology, 21(4), 383–389.

212. Caldwell J., Lunn R., & Ruder A. (1995). Tetrachloroethylene (perc, tetra, PCE). IARC Monographs, 63.

213. Pope C.A. et al. (2002). Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA, 287(9), 1132–1141.

214. Hayes R.B. et al. (2019). PM2.5 air pollution and cause-specific cardiovascular disease mortality. International Journal of Epidemiology. (In press at time of writing).

215. Calderon-Garciduenas L. et al. (2019). Air pollution, combustion and friction derived nanoparticles, and Alzheimer’s disease in urban children and young adults. Journal of Alzheimer’s Disease, 70(2), 343–360.

216. Bose S. et al. (2019). Prenatal particulate air pollution exposure and sleep disruption in preschoolers: Window of susceptibility. Environment International, 124, 329–335.

217. Turner M.C. et al. (2017). Ambient air pollution and cancer mortality in the Cancer Prevention Study II. Environmental Health Perspectives, 125(8).

218. Zhang Z. et al, 2018, ‘Exposure to nitrogen dioxide and chronic obstructive pulmonary disease (COPD) in adults: a systematic review and meta-analysis’, Environ Sci Pollut Res Int, vol 25, issue 15, pp 15133–15145.

219. Szyszkowicz M., Rowe B.H. and Kaplan G.G., 2009, ‘Ambient sulphur dioxide exposure and emergency department visits for migraine in Vancouver, Canada’, Int J Occup Med Environ Health, vol 22, issue 1, pp 7–12.

220. Deger L. et al, 2012, ‘Active and uncontrolled asthma among children exposed to air stack emissions of sulphur dioxide from petroleum refineries in Montreal, Quebec: a cross-sectional study’, Can Respir J, vol 19, issue 2, pp 97–102.

221. Bahadar H. et al, 2014, ‘Current understandings and perspectives on non-cancer health effects of benzene: a global concern’, Toxicol Appl Pharmacol, vol 276, issue 2, pp 83–94.

222. Bello-Medina P.C. et al, 2019, ‘Ozone pollution, oxidative stress, synaptic plasticity and neurodegeneration’, Neurologia. In press at the time of writing.

223. Greenberg M.M., 1997, ‘The central nervous system and exposure to toluene: a risk characterization’ Environ Res, vol 72, issue 1, pp 1–7.

224. Roshandel G. et al, 2012, ‘Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma’, Arch Iran Med, vol 15, issue 11, pp 713–722.

225. Karimi P. et al, 2015, ‘Polycyclic aromatic hydrocarbons and childhood asthma’, Eur J Epidemiol, vol 30, issue 2, pp 91–101.

226. Gankhuyag N. et al, 2017, ‘The role of Nitrosamine (NNK) in Breast Cancer Carcinogenesis’, J Mammary Gland Biol Neoplasia, vol 22, issue 3, pp 159–170.

227. Peterson L.A., 2017, ‘Context Matters: Contribution of Specific DNA Adducts to the Genotoxic Properties of the Tobacco-Specific Nitrosamine NNK’, Chem Res Toxicol, vol 30, issue 1, pp 420–433.

228. Lang A.L. and Beier J.I., 2018, ‘Interaction of volatile organic compounds and underlying liver disease: a new paradigm for risk’, Biol Chem, vol 399, issue 11, pp 1237–1248.

229. Di Carlo F.J. et al, 1978, ‘Assessment of the hazards of polybrominated biphenyls’, Environ Health Perspect, vol 23, pp 351–365.

230. Infante P.F. et al, 2009, ‘Vinyl chloride propellant in hair spray and angiosarcoma of the liver among hairdressers and barbers: case reports’, Int J Occup Environ Health, vol 15, issue 1, pp 36–42.

231. Environmental Working Group, 2012, ‘The Scent of Danger: Are there Toxic Ingredients in Perfumes and Colognes?’ Scientific American, 29th Sept 2012.

232. Sonne C. et al, 2004, ‘Is bone mineral composition disrupted by organochlorines in East Greenland polar bears (Ursus maritimus)?’, Environmental Health Perspectives, vol 112, issue 17, pp 1711–1716.

233. IARC – International Agency for Research on Cancer – ‘IARC Monographs vol 112: evaluation of five organophosphate insecticides and herbicides’, WHO (World Health Organisation), 20th March 2015.

234. National Toxicology Program of the US Department of Health and Human Services, Report on Carcinogens, 14th edition, 1,4–Dichlorobenzene, CAS No. 106–46–7.

235. Bang du Y., Lee I.K. and Lee B.M., 2011, ‘Toxicological characterisation of phthalic acid’, Toxicol Res, vol 27, issue 4, pp 191–203.

236. Gago-Dominguez M. et al, 2000, ‘Use of permanent hair dyes and bladder-cancer risk’, International Journal of Cancer, vol 91, issue 4, pp 575–579.

237. Waring R. and Klovrza L.V., 2000, ‘Sulphur Metabolism in Autism’, Journal of Nutritional and Environmental Medicine, vol 10, pp 25–32.

238. Ferenci P. et al, 1989, ‘Randomised controlled trial of silymarin treatment in patients with cirrhosis of the liver’, J Hepatol, vol 9, pp 105–13.

239. Anderson A., Cheng N., Bryden N.A. et al, 1997, ‘Elevated Intakes of Supplemental Chromium Improve Glucose and Insulin Variables in Individuals with Type 2 Diabetes’, Diabetes, 46(11): 1786–1791.

240. Lopez H.W., Leenhardt F., Coudray C. et al, 2002, ‘Minerals and phytic acid interactions: is it a real problem for human nutrition?’, Intl Jnl Food Science & Technol, 37(7): 727–739.

241. Coulibaly A., Kouakou B. and Chen J., 2011, ‘Review Article. Phytic Acid in Cereal Grains: Healthy or Harmful Ways to Reduce Phytic Acid in Cereal Grains and Their Effects on Nutritional Quality’, American Journal of Plant Nutrition and Fertilisation Technology, 1(1): 1–22.

242. Hotz C. and Gibson R.S., 2007, ‘Traditional Food-Processing and Preparation Practices to Enhance the Bioavailability of Micronutrients in Plant-Based Diets’, The Journal of Nutrition, 137(4): 1097–1100.

243. Freed D.L.J., 1991, ‘Lectins in Food: Their Importance in Health and Disease’, Journal of Nutritional Medicine, 2(1): 45–64.

244. Hadjivassiliou M. et al, 1996, ‘Does cryptic gluten sensitivity play a part in neurological illness?’ The Lancet, 347(8998): 369–371.

245. Whitely P. et al, 1999, ‘A gluten-free diet as an intervention for autism and associated spectrum disorders: preliminary findings’, Autism, 3(1): 45–65.

246. Mozaffarian D. et al, 2006, ‘Trans Fatty Acids and Cardiovascular Disease’, NEJM, 354: 1601–1613.

247. Boskou G. et al, 2006, ‘Content of trans, trans-2,4–decadienal in deep-fried and pan-fried potatoes’, European Journal of Lipid Science and Technology, 108(2): 109–115.

248. Bansal G. et al, 2009, ‘Analysis of trans fatty acids in deep frying oil by three different approaches’, Food Chemistry, 116(2): 535–541.

249. Chen Y. et al, 2014, ‘The analysis of trans fatty acid profiles in deep frying palm oil and chicken fillets with an improved gas chromatography method’, Food Control, 44: 191–197.

250. Peng C.Y. et al, 2017, ‘Effects of cooking method, cooking oil and food type on aldehyde emissions in cooking oil fumes’, Journal of Hazardous Materials, 324(B): 160–167.

251. Zahir E. et al, 2017, ‘Study of physicochemical properties of edible oil and evaluation of frying oil quality by Fourier Transform-Infrared (FT-IR) Spectroscopy’, Arabian Journal of Chemistry, 10(2): S3870–S3876.

252. Spector T., 2015, The Diet Myth, W&N, London.